Decreased SIRT3 was found to decrease IDH2 and SOD2 hyperacetylation by increasing the level of reactive oxygen species, suggesting that SIRT3 acts as a tumor suppressor in B cell malignancies. Here, IDH2 is linked to neoplasm.